Moreover, the disease-free survival (DFS) analysis suggested that upregulation of NUTF2 was significantly linked to poor prognosis of HNSC, KIRC, LGG, LUSC, PAAD, SARC, and UCS (p < 0.05) (Figure 1C). Here, NUTF2 is linked to pancreatic adenocarcinoma.